VivoSim Labs, Inc. (VIVS)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $2.58M
Last updated: Nov 17, 2026 at 11:05 AM ET
Performance (10Y)
Key Metrics
Technical Indicators Dashboard
As of Nov 16, 2026, the price is 35.3% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 35.0, in the neutral range between 30 and 70.
Moving Averages
MACD
ADX
Aroon & PSAR
Bollinger Bands
RSI (14-Day)
Momentum Oscillators
Volatility Measures
Volume Flow
Volume Metrics
Pivot Points
Advanced Oscillators
Financial Performance
Related GNG Research
No research available
Be the first to write about VIVS
News
VIVS Valuation
- P/B
- 0.3x
VIVS Profitability: Margins, ROIC and FCF
VivoSim Labs (VIVS) has a gross margin of 58.5%, an operating margin of -10117.0% and a net margin of 0.0%. It posts a -8245.2% FCF margin.
- Gross margin
- 58.5%
- Operating margin
- -10117.0%
- Net margin
- 0.0%
- ROE
- -343.1%
- FCF margin
- -8245.2%
VivoSim Labs Competitors
The companies most similar to VivoSim Labs (VIVS) include BioRestorative Therapies, Revelation Biosciences and Calidi Biotherapeutics.
Sector: Healthcare
Companies most similar to VivoSim LabsVIVS Bull Case vs Bear Case
Bull case
- VIVS beat EPS estimates in 87.5% of its last 8 reported quarters.
Bear case
- VIVS's quarterly revenue changed -51.4% year over year.
VIVS Earnings: Beat Rate
VivoSim Labs (VIVS) beat the EPS estimate in 7 of the 8 most recent quarters that had an estimate (87.5%).
- Beat rate
- 7 of 8 quarters (87.5%)
- Average surprise
- 50.8%
Updated Nov 12, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology
Frequently Asked Questions About VIVS
Does VIVS pay dividends?
VivoSim Labs, Inc. (VIVS) does not currently pay a regular dividend.
What is VIVS's market cap?
VivoSim Labs, Inc. (VIVS) has a market capitalization of $2.58M with a current stock price of $0.12.
VIVS pages: Overview, Earnings, Financials, Competitors
Get full access to GNG Research
Create a free account to access portfolio tracking, advanced tools, and more.